Project Grant F31MH143425
Award Date 2/1/27
Completion Date 9/15/28
Dollars Obligated $100K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Eugene, OR 97403, USA
Similar Awards
- The National Institute of Mental Health awarded the University of Oregon $346,214 on September 28, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study examining linkages between neighborhood environment and depressive symptoms in adolescent girls, with investigation of how pubertal development and sleep quality mediate or moderate that relationship. The study leverages the first five waves of the ongoing Transitions in Adolescent Girls (TAG) study,...
- The National Institute of Mental Health awarded Oregon Health & Science University $164,190 on December 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to fund a longitudinal study examining internalizing symptoms in adolescence through the lens of negative life events, emotion regulation dysfunction, and neurobiological mechanisms, with performance through July 31, 2029, at the Portland, Oregon campus. The research addresses the elevated prevalence and high...
- The National Institute of Mental Health awarded the University of Oregon $159,560 on January 1, 2027, under the Mental Health Research Grants program (CFDA 93.242) to conduct a study examining the bidirectional dynamics of daily behavior and mood associated with adolescent non-suicidal self-injury using passive mobile sensing. The research leverages passive smartphone data collection, including GPS technology and the Effortless Assessment of Risk States (EARS) platform, to observe associations...
- The National Institute of Mental Health awarded Oregon Research Behavioral Intervention Strategies, Inc. (doing business as Influents Innovations) $314,362 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to develop a digital evidence-based app for providers and teens addressing depression and subclinical depressive symptoms in youth. The project addresses the gap between the prevalence of depressive symptoms in adolescents and access to treatment. Cognitive...
- The National Institute of Mental Health awarded the Regents of the University of Minnesota $118,589 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate how neuroendocrine transitions during adolescence shape depression risk and salience network development. The research characterizes menarche and menstrual cycle stabilization as components of a neuroendocrine transition underlying adolescent vulnerability to depression. Aim 1 uses data from the...
- The National Institute of Mental Health awarded The Ohio State University $956,488 on September 15, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct longitudinal modeling of stress-induced rumination and depression risk in adolescent girls. The research employs a multimodal longitudinal study to test whether alterations in cognitive-affective brain networks—specifically salience, emotional, cognitive control, and default-mode networks—during stress-induced...
- The National Institute of Mental Health awarded the University of California, Los Angeles $393,750 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2026, to investigate bidirectional influences between social media use and adolescent depression through analysis of frontoparietal network connectivity. The research leverages five waves of longitudinal data from the Adolescent Brain Cognitive Development Study (N>10,000, ages 13–18) to examine associations among...
- The National Institute of Mental Health awarded the University of Illinois at Chicago $110,228 on January 1, 2027, under the Mental Health Research Grants program (CFDA 93.242) to investigate menstrual cycle effects on mood episodes and suicidality in adolescent female psychiatric patients. The project will examine whether cyclical fluctuations in ovarian hormones function as a biological trigger for suicidality in adolescents with brain sensitivity to hormonal changes. The study builds on a...
- The National Institute of Mental Health awarded the University of Pittsburgh $458,433 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop, refine, and validate a developmentally-tailored and ecologically-valid adolescent emotional faces stimulus set and examine the extent to which adolescents' socioaffective processing of these stimuli predicts unique variance in symptoms of anxiety, depression, suicidal ideation, and lifetime history of suicidal...
- The National Institute of Mental Health awarded the President and Fellows of Harvard College, through its Harvard T.H. Chan School of Public Health division, $418,000 on August 10, 2026, to identify epigenetic biomarkers that predict the risk and progression of depression among young adolescents under the Mental Health Research Grants program (CFDA 93.242). The recipient will investigate how DNA methylation and microRNA expression mediate the effects of early life stress on adolescent...